2m 2m 2m 2m 2m 2m 2m
IGC Pharma (IGC)
NYSE
$0.20-$0.004 (-1.96%)
Price as of Nov 12, 2026 8:41 AM EST- $23.2MMarket Cap
- -45.66%1-Year Change
- BiotechnologyIndustry
IGC Pharma (IGC)
$0.20-$0.004 (-1.96%)
IGC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.20 | ||
Change | +$0.003 (+1.48%) | ||
Open | $0.20 | ||
High | $0.20 | ||
Low | $0.19 | ||
Previous Close | $0.20 | ||
Volume | 193,411 | ||
30-Day Average Volume | 506,966 | ||
1-Week Change | 2.00% | ||
1-Month Change | -28.94% | ||
1-Year Change | -45.66% | ||
3-Year Change | -32.58% | ||
5-Year Change | -86.09% | ||
Fundamentals | |||
Shares Outstanding | 116.7M | ||
Total Assets | $9.7M | ||
Market Cap | $23.2M | ||
Enterprise Value | $23.7M | ||
Period: QTR TTM FY | |||
Revenue | $328,000.00 | ||
Net Income | -$2.0M | ||
Free Cash Flow | -$1.4M | ||
EBIT | -$2.0M | ||
EBITDA | -$2.0M | ||
Net Working Capital | -$1.8M | ||
EPS | -$0.02 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | 72 | ||
P/B | 4 | ||
P/E | -10 | ||
PEG | -0 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 04/19/2013 | ||
Earnings & Revenue